Hypoxic miRNAs expression are different between primary and metastatic melanoma cells

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• MicroRNAs (miRNAs) are crucial regulators of gene expression, responding rapidly to cellular stresses like hypoxia.
• Hypoxia-induced miRNAs (HRMs) influence multiple signaling pathways, making their identification significant in cancer research.
• Canine oral melanoma (COM) is an aggressive cancer where understanding cellular stress responses is clinically important.

Purpose of the Study:

• To identify hypoxia-regulated miRNAs (HRMs) in canine oral melanoma (COM).
• To investigate the clinical significance of HRMs in COM.
• To compare HRM profiles and responses between primary and metastatic COM cells.

Main Methods:

• Next-generation sequencing was used to profile miRNAs under hypoxic and normoxic conditions in COM cell lines.
• HRMs were identified by comparing miRNA expression in cell lines with COM tissue samples.
• Quantitative reverse transcription PCR (qRT-PCR) was employed for time-course expression analysis of specific miRNAs.

Main Results:

• Distinct HRM profiles were observed between primary and metastatic COM cell lines, with miR-301a and miR-8884 being exceptions.
• Metastatic COM cells exhibited greater resistance to hypoxia compared to primary cells, as indicated by miRNA expression dynamics.
• miR-21 and miR-301a were found to regulate a complex hypoxia-responsive gene network involving oncogenes like VEGF, PTEN, and TGFBR2.

Conclusions:

• The study successfully identified the HRM profile in canine oral melanoma.
• Significant differences in miRNA regulation and response to hypoxia exist between primary and metastatic COM cells.
• HRMs, particularly miR-21 and miR-301a, play a role in key oncogenic pathways relevant to COM progression.